R0 resection in the treatment of gastric cancer: room for improvement
- PMID: 20632437
- PMCID: PMC2904881
- DOI: 10.3748/wjg.v16.i27.3358
R0 resection in the treatment of gastric cancer: room for improvement
Abstract
Gastric carcinoma is one of the most frequent malignancies in the world and its clinical behavior especially depends on the metastatic potential of the tumor. In particular, lymphatic metastasis is one of the main predictors of tumor recurrence and survival, and current pathological staging systems reflect the concept that lymphatic spread is the most relevant prognostic factor in patients undergoing curative resection. This is compounded by the observation that two-thirds of gastric cancer in the Western world presents at an advanced stage, with lymph node metastasis at diagnosis. All current therapeutic efforts in gastric cancer are directed toward individualization of therapeutic protocols, tailoring the extent of resection and the administration of preoperative and postoperative treatment. The goals of all these strategies are to improve prognosis towards the achievement of a curative resection (R0 resection) with minimal morbidity and mortality, and better postoperative quality of life.
Similar articles
-
Surgical issues after neoadjuvant treatment for gastric cancer.Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):315-9. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496541 Review.
-
Current status and future perspectives in gastric cancer management.Cancer Treat Rev. 2000 Aug;26(4):243-55. doi: 10.1053/ctrv.2000.0164. Cancer Treat Rev. 2000. PMID: 10913380 Review.
-
[Stage-adapted radical principles in gastric carcinoma].Praxis (Bern 1994). 1998 Mar 25;87(13):447-50. Praxis (Bern 1994). 1998. PMID: 9584570 Review. German.
-
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9. Am J Clin Oncol. 2013. PMID: 22547011
-
Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.Br J Cancer. 2001 Jun 15;84(12):1602-9. doi: 10.1054/bjoc.2001.1720. Br J Cancer. 2001. PMID: 11401312 Free PMC article.
Cited by
-
Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.J Am Coll Surg. 2017 Apr;224(4):546-555. doi: 10.1016/j.jamcollsurg.2016.12.015. Epub 2016 Dec 23. J Am Coll Surg. 2017. PMID: 28017807 Free PMC article.
-
Role of Preoperative Radiation Therapy for Resectable Gastric Cancer.J Gastrointest Cancer. 2024 Jun;55(2):584-598. doi: 10.1007/s12029-023-00985-6. Epub 2024 Feb 14. J Gastrointest Cancer. 2024. PMID: 38353901 Review.
-
Laparoscopic Resection for Adenocarcinoma of the Stomach or Gastroesophageal Junction Improves Postoperative Outcomes: a Propensity Score Matching Analysis.J Gastrointest Surg. 2019 Apr;23(4):730-738. doi: 10.1007/s11605-018-3982-8. Epub 2018 Oct 3. J Gastrointest Surg. 2019. PMID: 30284200
-
Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach.Gut Liver. 2023 Mar 15;17(2):217-225. doi: 10.5009/gnl210454. Epub 2023 Feb 15. Gut Liver. 2023. PMID: 36789572 Free PMC article.
-
Cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2018 Sep;97(36):e12230. doi: 10.1097/MD.0000000000012230. Medicine (Baltimore). 2018. PMID: 30200148 Free PMC article. Review.
References
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Kubota H, Kotoh T, Masunaga R, Dhar DK, Shibakita M, Tachibana M, Kohno H, Nagasue N. Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution. Surgery. 2000;128:41–47. - PubMed
-
- Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237–2246. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical